Moreover, the 36-month beta value for AHCO is 1.09. Analysts have varying opinions on the stock, with 4 analysts rating it as a “buy,” 2 as “overweight,” 3 as “hold,” and 1 as “sell.”
The public float for AHCO is 83.27M and currently, short sellers hold a 9.61% of that float. On September 19, 2024, AHCO’s average trading volume was 1.13M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
AHCO) stock’s latest price update
AdaptHealth Corp (NASDAQ: AHCO)’s stock price has gone decline by -1.39 in comparison to its previous close of 11.49, however, the company has experienced a 0.98% increase in its stock price over the last five trading days. seekingalpha.com reported 2024-08-10 that AHCO shares are down 20% since my last report and are trading at ~10x trailing earnings. Economic characteristics continue to be a drag on corporate performance, likely justifying these multiples. Without an extensive runway to deploy capital and grow earnings, my view is the business is worth ~$11-$12/share today.
AHCO’s Market Performance
AHCO’s stock has risen by 0.98% in the past week, with a monthly rise of 6.59% and a quarterly rise of 0.80%. The volatility ratio for the week is 4.15% while the volatility levels for the last 30 days are 4.48% for AdaptHealth Corp The simple moving average for the last 20 days is 4.07% for AHCO’s stock, with a simple moving average of 18.89% for the last 200 days.
Analysts’ Opinion of AHCO
Many brokerage firms have already submitted their reports for AHCO stocks, with Jefferies repeating the rating for AHCO by listing it as a “Hold.” The predicted price for AHCO in the upcoming period, according to Jefferies is $8 based on the research report published on January 08, 2024 of the current year 2024.
BofA Securities, on the other hand, stated in their research note that they expect to see AHCO reach a price target of $6.50, previously predicting the price at $9.50. The rating they have provided for AHCO stocks is “Underperform” according to the report published on November 08th, 2023.
Stifel gave a rating of “Hold” to AHCO, setting the target price at $11 in the report published on May 10th of the previous year.
AHCO Trading at 6.20% from the 50-Day Moving Average
After a stumble in the market that brought AHCO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -4.79% of loss for the given period.
Volatility was left at 4.48%, however, over the last 30 days, the volatility rate increased by 4.15%, as shares surge +13.41% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +17.90% upper at present.
During the last 5 trading sessions, AHCO rose by +0.98%, which changed the moving average for the period of 200-days by +33.61% in comparison to the 20-day moving average, which settled at $10.95. In addition, AdaptHealth Corp saw 55.42% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AHCO starting from Richard A. Barasch, who proposed sale 40,022 shares at the price of $11.48 back on Sep 18 ’24. After this action, Richard A. Barasch now owns shares of AdaptHealth Corp, valued at $459,452 using the latest closing price.
Richard A. Barasch, the Former Affiliate of AdaptHealth Corp, proposed sale 14,970 shares at $11.13 during a trade that took place back on Sep 16 ’24, which means that Richard A. Barasch is holding shares at $166,616 based on the most recent closing price.
Stock Fundamentals for AHCO
Current profitability levels for the company are sitting at:
- -0.07 for the present operating margin
- 0.15 for the gross margin
The net margin for AdaptHealth Corp stands at -0.21. The total capital return value is set at -0.06. Equity return is now at value -37.80, with -14.27 for asset returns.
Based on AdaptHealth Corp (AHCO), the company’s capital structure generated 0.59 points at debt to capital in total, while cash flow to debt ratio is standing at 0.24. The debt to equity ratio resting at 1.43. The interest coverage ratio of the stock is -1.85.
Currently, EBITDA for the company is 661.04 million with net debt to EBITDA at 3.23. When we switch over and look at the enterprise to sales, we see a ratio of 1.13. The receivables turnover for the company is 7.46for trailing twelve months and the total asset turnover is 0.72. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.15.
Conclusion
To wrap up, the performance of AdaptHealth Corp (AHCO) has been better in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
